Focal edema† | p value | ||
---|---|---|---|
−(n = 103) | +(n = 102) | ||
Age in years, mean ± SD | 57.04 ± 12.01 | 58.69 ± 11.70 | 0.321 |
Tumor size on MRI in cm (IQR) | 1.7 (1.3~2.2) | 2.4 (1.9~3.2) | < 0.001 |
cT stage | |||
T1 | 73 | 36 | < 0.001 |
T2-3 | 30 | 66 | |
Grade* | |||
WHO I/II | 54 | 39 | 0.010 |
III | 26 | 43 | |
ER | |||
Status in percentage (IQR) | 90 (75~90) | 70 (0~90) | < 0.001 |
Negative | 11 | 33 | < 0.001 |
Positive | 92 | 69 | |
PR | |||
Status in percentage (IQR) | 70 (20~90) | 10 (0~70) | < 0.001 |
Negative | 18 | 37 | 0.002 |
Positive | 85 | 65 | |
Ki-67 | |||
Status in percentage (IQR) | 18 (10~30) | 30 (15~40) | < 0.001 |
Low, < 14% | 42 | 17 | < 0.001 |
High, ≥ 14% | 61 | 85 | |
HER-2 | |||
Negative | 92 | 80 | 0.034 |
Positive | 11 | 22 | |
LN status | |||
Negative | 78 | 63 | 0.031 |
Positive | 25 | 39 | |
pN stage** | |||
N0 | 78 | 63 | 0.114, N0 versus N1 0.814 |
N1 | 19 | 14 | N0 versus N2-3 0.011 |
N2-3 | 5 | 15 | N1 versus N2-3 0.021 |
LVI | |||
Negative | 90 | 98 | 0.073 |
Positive | 12 | 5 | |
Molecular subtype | |||
Luminal | 93 | 71 | < 0.001 |
Non-luminal | 10 | 31 |